Search by Drug Name or NDC

NDC 70934-0675-15 Benzonatate 100 mg/1 Details

Benzonatate 100 mg/1

Benzonatate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. dba Northwind Pharmaceuticals. The primary component is BENZONATATE.

MedlinePlus Drug Summary

Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.

Related Packages: 70934-0675-15
Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Benzonatate

Product Information

NDC	70934-0675
Product ID	70934-675_d0113967-5d31-db35-e053-2a95a90ada42
Associated GPIs	43102010000105
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Benzonatate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Benzonatate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	BENZONATATE
Labeler Name	Denton Pharma, Inc. dba Northwind Pharmaceuticals
Pharmaceutical Class	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA206948
Listing Certified Through	n/a

Package

NDC 70934-0675-15 (70934067515)

Pricing Information	N/A
NDC Package Code	70934-675-15
Billing NDC	70934067515
Package	15 CAPSULE in 1 BOTTLE, PLASTIC (70934-675-15)
Marketing Start Date	2021-10-29
NDC Exclude Flag	N